Eli Lilly and Company


Baxter drug fails to slow Alzheimer’s in big study

DEERFIELD, Ill. (AP) — Baxter International Inc. says that a blood product it was testing failed to slow mental decline or to preserve physical function in a major study of 390 patients with mild to […]



Lilly drug chosen for Alzheimer’s prevention study

(AP) – Researchers have chosen an experimental drug by Eli Lilly & Co. for a large federally funded study aiming to prevent Alzheimer’s disease in older people at high risk of developing it.


Scientists in drug research lab

Study: Hundreds of rare disease drugs in testing

(AP) — For the nearly 30 million Americans who suffer from a rare disease, there’s heartening news: Drugmakers are now researching uncommon disorders that often kill prematurely because of few or no treatment options.



New Alzheimer’s drug studies offer patients hope

TRENTON, N.J. (AP) – For Alzheimer’s patients desperate for an effective treatment, several new studies starting up offer hope.

After dozens of promising experimental drugs failed, scientists think they’re now on the right track.